Download FREE Report Sample
Download Free sampleEndocannabinoid System Targeted Therapeutics refers to the use of the endocannabinoid system as a therapeutic target to treat some diseases
Endocannabinoid System Targeted Therapeutics Market contains market size and forecasts of Endocannabinoid System Targeted Therapeutics in Global, including the following market information:
Global Endocannabinoid System Targeted Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Endocannabinoid System Targeted Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Endocannabinoid System Targeted Therapeutics include GW Pharmaceuticals, MAKScientific, Corbus Pharmaceuticals, Tilray, Pure Green, Avicanna, GB Sciences, Botanix Pharmaceuticals and Therapix Biosciences and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Endocannabinoid System Targeted Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endocannabinoid System Targeted Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Endocannabinoid System Targeted Therapeutics Market Segment Percentages, by Type, 2021 (%)
Oral
Inhalation
Others
Global Endocannabinoid System Targeted Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Endocannabinoid System Targeted Therapeutics Market Segment Percentages, by Application, 2021 (%)
Autoimmune Disorders
Genetic Disorders
Neurological Disorders
Pain Disorders
Global Endocannabinoid System Targeted Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Endocannabinoid System Targeted Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endocannabinoid System Targeted Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Endocannabinoid System Targeted Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GW Pharmaceuticals
MAKScientific
Corbus Pharmaceuticals
Tilray
Pure Green
Avicanna
GB Sciences
Botanix Pharmaceuticals
Therapix Biosciences
Zelira Therapeutics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
